pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-3152 |
Genomic Coordinates | chr9: 18573306 - 18573379 |
Description | Homo sapiens miR-3152 stem-loop |
Comment | Berezikov et al. proposed this sequence as a miRNA candidate based on the RAKE method . |
RNA Secondary Structure |
Mature miRNA Information | ||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-3152-3p | |||||||||||||||||||||||||||||||||
Sequence | 45| UGUGUUAGAAUAGGGGCAAUAA |66 | |||||||||||||||||||||||||||||||||
Evidence | Experimental | |||||||||||||||||||||||||||||||||
Experiments | Illumina | DRVs in miRNA |
|
|||||||||||||||||||||||||||||||
SNPs in miRNA |
|
|||||||||||||||||||||||||||||||||
Putative Targets |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | CRCP | ||||||||||||||||||||
Synonyms | CGRP-RCP, CGRPRCP, RCP, RCP9 | ||||||||||||||||||||
Description | CGRP receptor component | ||||||||||||||||||||
Transcript | NM_001040647 | ||||||||||||||||||||
Other Transcripts | NM_001040648 , NM_001142414 , NM_014478 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on CRCP | |||||||||||||||||||||
3'UTR of CRCP (miRNA target sites are highlighted) |
>CRCP|NM_001040647|3'UTR 1 AAGAGCACAGCTGGCCCCGGCGTTTCATGAAGTCAGAAGGCCTGGCAGCCATTTCCTGGACGTTGAGAGGATTGTTTATT 81 TGATTTTTATCCTCATCCCAGCAGGCCTGGCTTTGTGGTTAGTTGGGTACATCACAAAAATAAGTTAAAAAGAAATATTT 161 GTGCCTTGGGGAGAAGAAACATGGTGAAAACAGGCTGAGGTTGTCAGGGCAGAGAGCTGAAGGTGGGGACAGTGACCGCG 241 GACCCCTCTGTGCTTGAAAGATTTCCTCCACGGCCTTTGCCCCAGTTGTGGGGAGGTCTCTGTGCACAGCGGGGAAAATG 321 CTTGTGTCGCCTTTGGTGGGCCATGTCCTAATTAGTTTCATCTGCTTCCCTGGGAACTTACTAAGGGGCCCAGAGCACTG 401 TTGGAAGTCTGGTTAGAGTCCCCAGAGAGTTACTCTAAGTTAAAATGAGCCACTGACCTTGGCTCACCTTAGAGGAATTT 481 CCTCGAGAACAACAGAGATAAGAAAAGAACCGGCCTGGCCAATCCTTCAACAGCTCTAGAGCCCCTTTTCTCTGCTGGCA 561 GGGGCTTTGTTTACCAGCTCACTGTTTAGGCTAAATGTTAGGGACCAGATCACTGCAGTTGAAAACGGGCACTCCAGGCT 641 TAGTGACAGTGGCAGCAGAAACAGTGTTGGCTGCCTTTCTGACCACCCCACTTTCCTGCCCTGAGACAGCAGCCCAGGGC 721 AGGTGCTTCATATTCAGACCAGGTAAGCCTCATTTGCACAACAGTCAAATTGTTTGTTCCTTTAAAAAGGACACAATTAG 801 CCTGGCACGGTGACTCATGCTTGTAATCCCAGCACTTTGGGAGGGCAAGGCAGGCGGATCACCTGAGGTCAGGAGTTTGA 881 GACCAGCCTCACCAACATGGAAAAACCCCATCTCTACTAAAAAAATACAAAATTAACCAGGGGTGATGGCACATTCCTGT 961 AATCCCAGCTACTCGGGAGGCCGAGGCAGGAGAATCGCTTGAACCCGGGAGGCAGAGGTTGAGGTGAGCCAAGATTGCAC 1041 CATTGCACTCCAGCCTGGGCAACAAGAGCAAAACTTCATCTAAAAAACAGAAAATATTAAGATGATTACCATGTGAAAAC 1121 CTTTTTAATATTCAGGATTTGGAAAGTATAGTTGCCCCAGGCATGTGGTTGTTGCCTTAGGTCCTGCGAATATTGCTGAA 1201 AATCGGATTTTCCACATTCACTTTCTTCCCTGTTTTAGGGAAGAAAATGATCATAGACATTCGATTTTCCAAATTGGCGC 1281 TCTTATTTTCAATGCTAATTGGATTACTTCTCTTCCAACCCTCCTGCCCGTCCATCCATCCCAGTCCCCAGGCATCTTAA 1361 CCTTACCATCTGAGCTTCAGCTGAAATCTGTTTATAGGCAACATTGAAAGTACCAGATTGGGGCCAGGTGTAGCGGCCCA 1441 CACCTGTAATCCCAGCACTTTGGGAGGCGGAGGCTAGCGGATCATGAGGTCAGGAGTTCAAGACCAGCCTGGCCAACATG 1521 GTGAAACCCCCATCTCTACTAAAGATATAAAAAACTAGCCGAGCGTGGTGTTGCATGCCTGTGATCCCAGCTACTCGGGA 1601 GGCTGAGGCGGGGGAATCGCTTGAACCGGGGAGGCAGAGGTTGCAGTGAGCCAGATCGTGCATTGCACTCCAGCCTGGCC 1681 GACAGGGTGAGACTCCATCTCAAAAAAGAGAAAGTACCAGATTGTACTTTTAAATCTGTCTAGCGTATTGAGAATTTTAG 1761 TGGGAGCTGTTGATTTATTTCTCAGGGCATACATGTGCCAATCTGTCTCATTGTTGTCTCTCTCTTTTTTTTTTTTTTTT 1841 TTGAGACAGTCTCGCTGTGTTGCCCAGGAGTGCAGTGGCACGATCTCTGCTCACTGCAACCTCTGCCTCCCAGATTCAAG 1921 CGATTCTGGTGCCTTAGCCTCCTGAGTAGCTGGGACTTACAGGCACGTACCACTATACCCTGCTAAAATTTGTATTTTTA 2001 GTAGAGACAGGGTTTTGCCATATTGGCCAGGCTAGTCGTAATGTCTCTTTTTAACACTGAATATGTTAGGTGGTTTTTCT 2081 TGATGGATTTAGGGTTAACCTAGTTAATAATAAATTGTTTCCAGGTAATTATCAAGTTTTGTCATTTTATAAATCTGAAG 2161 AGTTAATATTGTCATCGATACAAATAAAGTGAAATCTGACTGAGGCTAAAAAAAAAAAAAAAAAAAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 27297.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065667. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM1065667 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_6 |
Location of target site | ENST00000415001.2 | 3UTR | CUGGCUAACACGGUGAAACCCUUCU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | ||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
60 hsa-miR-3152-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT068760 | RB1 | RB transcriptional corepressor 1 | 2 | 2 | ||||||||
MIRT142268 | DCTN5 | dynactin subunit 5 | 2 | 8 | ||||||||
MIRT179443 | TBRG1 | transforming growth factor beta regulator 1 | 2 | 2 | ||||||||
MIRT221382 | DNAJB6 | DnaJ heat shock protein family (Hsp40) member B6 | 2 | 6 | ||||||||
MIRT332510 | CD81 | CD81 molecule | 2 | 2 | ||||||||
MIRT442419 | KCNN3 | potassium calcium-activated channel subfamily N member 3 | 2 | 2 | ||||||||
MIRT445519 | PLXDC2 | plexin domain containing 2 | 2 | 2 | ||||||||
MIRT464185 | VMA21 | VMA21, vacuolar ATPase assembly factor | 2 | 2 | ||||||||
MIRT467933 | SLC16A6 | solute carrier family 16 member 6 | 2 | 2 | ||||||||
MIRT468378 | SETD5 | SET domain containing 5 | 2 | 2 | ||||||||
MIRT468486 | SESN3 | sestrin 3 | 2 | 2 | ||||||||
MIRT468928 | RPS24 | ribosomal protein S24 | 2 | 2 | ||||||||
MIRT478171 | DENND5B | DENN domain containing 5B | 2 | 2 | ||||||||
MIRT490447 | GLUD1 | glutamate dehydrogenase 1 | 2 | 2 | ||||||||
MIRT494675 | ARL5B | ADP ribosylation factor like GTPase 5B | 2 | 2 | ||||||||
MIRT502287 | GNG5 | G protein subunit gamma 5 | 2 | 6 | ||||||||
MIRT506078 | PPP2CA | protein phosphatase 2 catalytic subunit alpha | 2 | 6 | ||||||||
MIRT508008 | BCAT1 | branched chain amino acid transaminase 1 | 2 | 4 | ||||||||
MIRT508760 | IPP | intracisternal A particle-promoted polypeptide | 2 | 2 | ||||||||
MIRT509091 | SYNPO2L | synaptopodin 2 like | 2 | 4 | ||||||||
MIRT511968 | EIF1AX | eukaryotic translation initiation factor 1A, X-linked | 2 | 4 | ||||||||
MIRT515210 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT516377 | TRAF3IP2 | TRAF3 interacting protein 2 | 2 | 4 | ||||||||
MIRT517047 | ZNF678 | zinc finger protein 678 | 2 | 2 | ||||||||
MIRT521125 | SHROOM4 | shroom family member 4 | 2 | 2 | ||||||||
MIRT521277 | RTF1 | RTF1 homolog, Paf1/RNA polymerase II complex component | 2 | 2 | ||||||||
MIRT522772 | LAMP2 | lysosomal associated membrane protein 2 | 2 | 6 | ||||||||
MIRT524419 | CNKSR3 | CNKSR family member 3 | 2 | 2 | ||||||||
MIRT529398 | ICK | intestinal cell kinase | 2 | 2 | ||||||||
MIRT529965 | PHF7 | PHD finger protein 7 | 2 | 2 | ||||||||
MIRT530189 | TIGD2 | tigger transposable element derived 2 | 2 | 2 | ||||||||
MIRT533716 | TMEM30A | transmembrane protein 30A | 2 | 2 | ||||||||
MIRT543170 | FICD | FIC domain containing | 2 | 2 | ||||||||
MIRT548496 | E2F8 | E2F transcription factor 8 | 2 | 2 | ||||||||
MIRT555020 | RAB23 | RAB23, member RAS oncogene family | 2 | 2 | ||||||||
MIRT560728 | ZNF529 | zinc finger protein 529 | 2 | 10 | ||||||||
MIRT564890 | YTHDF3 | YTH N6-methyladenosine RNA binding protein 3 | 2 | 2 | ||||||||
MIRT567327 | HMGB1 | high mobility group box 1 | 2 | 2 | ||||||||
MIRT568035 | CLIP4 | CAP-Gly domain containing linker protein family member 4 | 2 | 2 | ||||||||
MIRT574763 | FLVCR1 | feline leukemia virus subgroup C cellular receptor 1 | 2 | 2 | ||||||||
MIRT620811 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT622456 | RNF19B | ring finger protein 19B | 2 | 2 | ||||||||
MIRT636240 | SIM1 | single-minded family bHLH transcription factor 1 | 2 | 2 | ||||||||
MIRT643231 | MUC15 | mucin 15, cell surface associated | 2 | 2 | ||||||||
MIRT646319 | CAPZA2 | capping actin protein of muscle Z-line alpha subunit 2 | 2 | 2 | ||||||||
MIRT646674 | CCDC69 | coiled-coil domain containing 69 | 2 | 2 | ||||||||
MIRT650043 | VHL | von Hippel-Lindau tumor suppressor | 2 | 2 | ||||||||
MIRT652533 | TM9SF3 | transmembrane 9 superfamily member 3 | 2 | 2 | ||||||||
MIRT663022 | CD40LG | CD40 ligand | 2 | 2 | ||||||||
MIRT667465 | MAPK10 | mitogen-activated protein kinase 10 | 2 | 2 | ||||||||
MIRT668620 | EEA1 | early endosome antigen 1 | 2 | 2 | ||||||||
MIRT675678 | SLC35F5 | solute carrier family 35 member F5 | 2 | 2 | ||||||||
MIRT681814 | N4BP2L2 | NEDD4 binding protein 2 like 2 | 2 | 2 | ||||||||
MIRT682674 | CPM | carboxypeptidase M | 2 | 2 | ||||||||
MIRT701447 | NFIC | nuclear factor I C | 2 | 2 | ||||||||
MIRT706222 | C20orf144 | chromosome 20 open reading frame 144 | 2 | 2 | ||||||||
MIRT707510 | PPP1R16B | protein phosphatase 1 regulatory subunit 16B | 2 | 2 | ||||||||
MIRT710466 | ASTN2 | astrotactin 2 | 2 | 2 | ||||||||
MIRT712957 | SGCD | sarcoglycan delta | 2 | 2 | ||||||||
MIRT723030 | MYLIP | myosin regulatory light chain interacting protein | 2 | 2 |
miRNA-Drug Associations | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|